Passage Bio
PASG
48 hedge funds and large institutions have $54.4M invested in Passage Bio in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 9 closing their positions.
4,700% more call options, than puts
Call options by funds: $48K | Put options by funds: $1K
64% more capital invested
Capital invested by funds: $33.1M → $54.4M (+$21.3M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
0.64% more ownership
Funds ownership: 2.99% → 3.62% (+0.64%)
4% less funds holding
Funds holding: 50 → 48 (-2)
14% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 14
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
Top Sellers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$1.08M |
| 2 |
EAM
Erste Asset Management
Vienna,
Austria
|
-$608K |
| 3 |
PFCS
Pale Fire Capital SE
Prague,
Czech Republic
|
-$529K |
| 4 |
BlackRock
New York
|
-$120K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$108K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TSS
51
Two Sigma Securities
New York
| – | -$40.7K | -2,016 | Closed |
|
|
SRL
52
Scientech Research LLC
Jersey City,
New Jersey
| – | -$19K | -943 | Closed |
|
53
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$18.7K | -927 | Closed |
|
54
Bank of New York Mellon
New York
| – | -$13.8K | -682 | Closed |
|
55
Simplex Trading
Chicago,
Illinois
| – | -$2.5K | -104 | Closed |
|
56
UBS Group
Zurich,
Switzerland
| – | -$1.07K | -53 | Closed |
|
|
SPIA
57
Steward Partners Investment Advisory
New York
| – | -$1.02K | -51 | Closed |
|
PASG Hedge Fund Activity: Q1 2024 in Review
48 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Passage Bio (PASG) for Q1 2024, worth a combined $54.4M — up 64% from $33.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of PASG and 7 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 12 added.
The largest buyer was Vestal Point Capital, opening a new position worth an estimated $5.41M. The largest seller was Tang Capital Management, cutting an estimated $1.08M.
- 48 institutional investors held Passage Bio (PASG) as of Q1 2024, down from 50 in Q4 2023.
- Funds reported $54.4M of Passage Bio stock for Q1 2024, up 64% quarter-over-quarter.
- 7 funds opened new Passage Bio positions in Q1 2024 and 9 closed out, a net change of -2 holders.
- The largest Passage Bio buyer in Q1 2024 was Vestal Point Capital, an estimated $5.41M added.
- The largest Passage Bio seller in Q1 2024 was Tang Capital Management, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2024.